|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:S6243–S6249. 2006. View Article : Google Scholar
|
|
3
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ranganathan K and Sivasankar V: MicroRNAs
- Biology and clinical applications. J Oral Maxillofac Pathol.
18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YL, Wu S, Jiang B, Yin FF, Zheng SS
and Hou SC: Role of microRNAs in prostate cancer pathogenesis. Clin
Genitourin Cancer. 13:261–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang LH, Tsai SY, Cook RG, Beattie WG,
Tsai MJ and O'Malley BW: COUP transcription factor is a member of
the steroid receptor superfamily. Nature. 340:163–166. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang K, Rubenstein JL, Tsai SY and Tsai
MJ: COUP-TFII controls amygdala patterning by regulating neuropilin
expression. Development. 139:1630–1639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L, Xie X, Qin J, Jeha GS, Saha PK, Yan
J, Haueter CM, Chan L, Tsai SY and Tsai MJ: The nuclear orphan
receptor COUP-TFII plays an essential role in adipogenesis, glucose
homeostasis, and energy metabolism. Cell Metab. 9:77–87. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ
and Tsai SY: Suppression of Notch signalling by the COUP-TFII
transcription factor regulates vein identity. Nature. 435:98–104.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu CT, Tang K, Suh JM, Jiang R, Tsai SY
and Tsai MJ: COUP-TFII is essential for metanephric mesenchyme
formation and kidney precursor cell survival. Development.
139:2330–2339. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin J, Chen X, Xie X, Tsai MJ and Tsai SY:
COUP-TFII regulates tumor growth and metastasis by modulating tumor
angiogenesis. Proc Natl Acad Sci USA. 107:3687–3692. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin J, Tsai SY and Tsai MJ: The critical
roles of COUP-TFII in tumor progression and metastasis. Cell
Biosci. 4:582014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Navab R, Gonzalez-Santos JM, Johnston MR,
Liu J, Brodt P, Tsao MS and Hu J: Expression of chicken ovalbumin
upstream promoter-transcription factor II enhances invasiveness of
human lung carcinoma cells. Cancer Res. 64:5097–5105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao Y, Gu D, Feng W, Sun X, Wang X, Zhang
X, Shi Q, Cui G, Yu H, Tang C, et al: COUP-TFII regulates
metastasis of colorectal adenocarcinoma cells by modulating Snail1.
Br J Cancer. 111:933–943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Polvani S, Tarocchi M, Tempesti S, Mello
T, Ceni E, Buccoliero F, D'Amico M, Boddi V, Farsi M, Nesi S, et
al: COUP-TFII in pancreatic adenocarcinoma: Clinical implication
for patient survival and tumor progression. Int J Cancer.
134:1648–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin J, Wu SP, Creighton CJ, Dai F, Xie X,
Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, et al: COUP-TFII
inhibits TGF-β-induced growth barrier to promote prostate
tumorigenesis. Nature. 493:236–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin SC, Kao CY, Lee HJ, Creighton CJ,
Ittmann MM, Tsai SJ, Tsai SY and Tsai MJ: Dysregulation of
miRNAs-COUP-TFII -FOXM1-CENPF axis contributes to the metastasis of
prostate cancer. Nat Commun. 7:114182016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou B, Song J, Han T, Huang M, Jiang H,
Qiao H, Shi J and Wang Y: MiR-382 inhibits cell growth and invasion
by targeting NR2F2 in colorectal cancer. Mol Carcinog. Jan
22–2016.(Epub ahead of print). doi: 10.1002/mc.22466. View Article : Google Scholar
|
|
23
|
Tan H, He Q, Gong G, Wang Y, Li J, Wang J,
Zhu D and Wu X: miR-382 inhibits migration and invasion by
targeting ROR1 through regulating EMT in ovarian cancer. Int J
Oncol. 48:181–190. 2016.PubMed/NCBI
|
|
24
|
Qi B, Lu JG, Yao WJ, Chang TM, Qin XG, Ji
YH, Wang TY, Liu SG, Li HC, Liu YZ, et al: Downregulation of
microRNA-382 is associated with poor outcome of esophageal squamous
cell carcinoma. World J Gastroenterol. 21:6884–6891.
2015.PubMed/NCBI
|
|
25
|
Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ
and Wang Y: miR-382 inhibits tumor growth and enhance
chemosensitivity in osteosarcoma. Oncotarget. 5:9472–9483. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thériault BL, Basavarajappa HD, Lim H,
Pajovic S, Gallie BL and Corson TW: Transcriptional and epigenetic
regulation of KIF14 overexpression in ovarian cancer. PLoS One.
9:e915402014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu M, Jin H, Xu CX, Sun B, Song ZG, Bi WZ
and Wang Y: miR-382 inhibits osteosarcoma metastasis and relapse by
targeting Y box-binding protein 1. Mol Ther. 23:89–98. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanniford D, Segura MF, Zhong J, Philips
E, Jirau-Serrano X, Darvishian F, Berman RS, Shapiro RL, Pavlick
AC, Brown B, et al: Identification of metastasis-suppressive
microRNAs in primary melanoma. J Natl Cancer Inst. 107:1072015.
View Article : Google Scholar
|
|
29
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the
tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res.
42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bei Y, Song Y, Wang F,
Dimitrova-Shumkovska J, Xiang Y, Zhao Y, Liu J, Xiao J and Yang C:
miR-382 targeting PTEN-Akt axis promotes liver regeneration.
Oncotarget. 7:1584–1597. 2016.PubMed/NCBI
|
|
31
|
Nagasaki S, Suzuki T, Miki Y, Akahira J,
Shibata H, Ishida T, Ohuchi N and Sasano H: Chicken ovalbumin
upstream promoter transcription factor II in human breast
carcinoma: Possible regulator of lymphangiogenesis via vascular
endothelial growth factor-C expression. Cancer Sci. 100:639–645.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shin SW, Kwon HC, Rho MS, Choi HJ, Kwak JY
and Park JI: Clinical significance of chicken ovalbumin upstream
promoter-transcription factor II expression in human colorectal
cancer. Oncol Rep. 21:101–106. 2009.PubMed/NCBI
|
|
33
|
Hawkins SM, Loomans HA, Wan YW,
Ghosh-Choudhury T, Coffey D, Xiao W, Liu Z, Sangi-Haghpeykar H and
Anderson ML: Expression and functional pathway analysis of nuclear
receptor NR2F2 in ovarian cancer. J Clin Endocrinol Metab.
98:E1152–E1162. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin J, Tsai S and Tsai MJ: COUP-TFII, a
prognostic marker and therapeutic target for prostate cancer. Asian
J Androl. 15:360–361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song CH, Lee HJ, Park E and Lee K: The
chicken ovalbumin upstream promoter-transcription factor II
negatively regulates the transactivation of androgen receptor in
prostate cancer cells. PLoS One. 7:e490262012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Litchfield LM, Appana SN, Datta S and
Klinge CM: COUP-TFII inhibits NFkappaB activation in
endocrine-resistant breast cancer cells. Mol Cell Endocrinol.
382:358–367. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakshatri H, Mendonca MS, Bhat-Nakshatri
P, Patel NM, Goulet RJ Jr and Cornetta K: The orphan receptor
COUP-TFII regulates G2/M progression of breast cancer cells by
modulating the expression/activity of p21(WAF1/CIP1), cyclin D1,
and cdk2. Biochem Biophys Res Commun. 270:1144–1153. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rosa A and Brivanlou AH: A regulatory
circuitry comprised of miR-302 and the transcription factors OCT4
and NR2F2 regulates human embryonic stem cell differentiation. EMBO
J. 30:237–248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu S, Wilson KD, Ghosh Z, Han L, Wang Y,
Lan F, Ransohoff KJ, Burridge P and Wu JC: MicroRNA-302 increases
reprogramming efficiency via repression of NR2F2. Stem Cells.
31:259–268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kang IH, Jeong BC, Hur SW, Choi H, Choi
SH, Ryu JH, Hwang YC and Koh JT: MicroRNA-302a stimulates
osteoblastic differentiation by repressing COUP-TFII expression. J
Cell Physiol. 230:911–921. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jeong BC, Kang IH, Hwang YC, Kim SH and
Koh JT: MicroRNA-194 reciprocally stimulates osteogenesis and
inhibits adipogenesis via regulating COUP-TFII expression. Cell
Death Dis. 5:e15322014. View Article : Google Scholar : PubMed/NCBI
|
